Biochem Pharmacol (2018) 156:40619
Like Hashimotos disease, its considered an autoimmune condition
Results on the long term efficacy, safety, and tolerability, from ongoing Phase III clinical trials will impact the therapeutic prospects and future directions of incretin-based agonist therapy
Who should consider vitamin B12 shots
GHK-CU remains a research compound without official dosing guidelines, which means protocols rely on accumulated practitioner experience and extrapolation from laboratory studies
Treatment for B12 deficiency without neurological involvement: For patients with haematological manifestations only (macrocytic anaemia) or asymptomatic deficiency, the regimen is hydroxocobalamin 1mg intramuscularly three times weekly for two weeks (total of six injections), followed by maintenance of 1mg every three months for life